Antitumor imide derivatives of 7-oxabicyclo[2.2.1]heptane-2,3-dimethyl-2,3-dicarboxylic acid.
The imide and methylimide derivatives of 7-oxobicyclo[2.2.1]heptane-2,3-dimethyl-2,3-dicarboxylic acid were synthesized and shown to have antitumor inhibitory activity (growth inhibition) against the KB cell line. The compounds were prepared according to standard procedures. Interest in the respective imide derivatives stemmed from their structural relationship to antitumor-active derivatives of 7-oxobicyclo[2.2.1]heptane-2,3-dicarboxylic acid which lacked 2,3-dimethyl substituents or which were derivatives of isoindolines and lacked the carbonyl groups.
Walter
W G
WG
Medical University of South Carolina, Department of Pharmaceutical Sciences, Charleston 29425.
D000970:Antineoplastic Agents / Q000138:chemical synthesis*; D002193:Cantharidin / Q000031:analogs & derivatives* / Q000032:analysis / Q000138:chemical synthesis* / Q000494:pharmacology; D002460:Cell Line; D006801:Humans; D007094:Imides; D054833:Isoindoles; D007624:KB Cells; D009682:Magnetic Resonance Spectroscopy
D000970:Antineoplastic Agents; D007094:Imides; D054833:Isoindoles; C059314:hexahydro-3a,7a-dimethyl-4,7-epoxy-1H-isoindole-1,3(2H)-dione; C059315:cantharidin methylimide; D002193:Cantharidin